Longitudinal Immunomonitoring Following Tocilizumab in Rheumatoid Arthritis

Journal of Translational Medicine - United Kingdom
doi 10.1186/1479-5876-9-s2-p19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Immunotherapy of Tocilizumab for Rheumatoid Arthritis

Journal of Clinical & Cellular Immunology
2013English

FRI0248 Incidence of Melanoma in Patients With Rheumatoid Arthritis Treated With Tocilizumab

2017English

Dramatic Radiographic Repair by Tocilizumab in a Very Elderly Patient With Rheumatoid Arthritis

Modern Rheumatology
MedicineRheumatology
2013English

Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Acute Anterior Uveitis After Discontinuation of Tocilizumab in a Patient With Rheumatoid Arthritis

Clinical Ophthalmology
Ophthalmology
2014English

Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis

Archives of Rheumatology
Rheumatology
2019English

Pms44 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Following Up Patients With Rheumatoid Arthritis.

BMJ
1980English

Tocilizumab in Refractory Rheumatoid Arthritis: Long-Term Efficacy, Safety, and Tolerability Beyond 2 Years

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy